Skeletal Muscle Fiber Adaptations Following Resistance Training Using Repetition Maximums or Relative Intensity by Carroll, Kevin M. et al.
Sacred Heart University
DigitalCommons@SHU
Exercise Science Faculty Publications Physical Therapy & Human Movement Science
7-2019
Skeletal Muscle Fiber Adaptations Following
Resistance Training Using Repetition Maximums
or Relative Intensity
Kevin M. Carroll
East Tennessee State University
Caleb D. Bazyler
East Tennessee State University
Jake R. Bernards
East Tennessee State University
Christopher Taber
Sacred Heart University, taberc@sacredheart.edu
Charles A. Stuart
East Tennessee State University
See next page for additional authors
Follow this and additional works at: https://digitalcommons.sacredheart.edu/pthms_exscifac
Part of the Exercise Science Commons
This Peer-Reviewed Article is brought to you for free and open access by the Physical Therapy & Human Movement Science at
DigitalCommons@SHU. It has been accepted for inclusion in Exercise Science Faculty Publications by an authorized administrator of
DigitalCommons@SHU. For more information, please contact ferribyp@sacredheart.edu, lysobeyb@sacredheart.edu.
Recommended Citation
Carroll, K. M., Bazyler, C. D., Bernards, J. R., Taber, C. B., Stuart, C. A., DeWeese, B. H., Sato, K., & Stone, M. H. (2019). Skeletal
muscle fiber adaptations following resistance training using repetition maximums or relative intensity. Sports, 7(7), 169. Doi: doi.org/
10.3390/sports7070169
Authors
Kevin M. Carroll, Caleb D. Bazyler, Jake R. Bernards, Christopher Taber, Charles A. Stuart, Brad H. Deweese,
Kimitake Sato, and Michael H. Stone
This peer-reviewed article is available at DigitalCommons@SHU: https://digitalcommons.sacredheart.edu/pthms_exscifac/38
sports
Article
Skeletal Muscle Fiber Adaptations Following
Resistance Training Using Repetition Maximums
or Relative Intensity
Kevin M. Carroll 1,*, Caleb D. Bazyler 1 , Jake R. Bernards 1 , Christopher B. Taber 2 ,
Charles A. Stuart 3, Brad H. DeWeese 1, Kimitake Sato 1 and Michael H. Stone 1
1 Department of Sport, Exercise, Recreation, and Kinesiology, East Tennessee State University, Johnson City,
TN 37614, USA
2 Department of Exercise Science, College of Health Professions, Sacred Heart University, Fairfield, CT 06825,
USA
3 Department of Internal Medicine, Quillen College of Medicine, East Tennessee State University, Johnson City,
TN 37614, USA
* Correspondence: carrollke@montclair.edu
Received: 18 June 2019; Accepted: 7 July 2019; Published: 11 July 2019


Abstract: The purpose of the study was to compare the physiological responses of skeletal muscle
to a resistance training (RT) program using repetition maximum (RM) or relative intensity (RISR).
Fifteen well-trained males underwent RT 3 d·wk−1 for 10 weeks in either an RM group (n = 8) or
RISR group (n = 7). The RM group achieved a relative maximum each day, while the RISR group
trained based on percentages. The RM group exercised until muscular failure on each exercise,
while the RISR group did not reach muscular failure throughout the intervention. Percutaneous
needle biopsies of the vastus lateralis were obtained pre-post the training intervention, along with
ultrasonography measures. Dependent variables were: Fiber type-specific cross-sectional area (CSA);
anatomical CSA (ACSA); muscle thickness (MT); mammalian target of rapamycin (mTOR); adenosine
monophosphate protein kinase (AMPK); and myosin heavy chains (MHC) specific for type I (MHC1),
type IIA (MHC2A), and type IIX (MHC2X). Mixed-design analysis of variance and effect size using
Hedge’s g were used to assess within- and between-group alterations. RISR statistically increased
type I CSA (p = 0.018, g = 0.56), type II CSA (p = 0.012, g = 0.81), ACSA (p = 0.002, g = 0.53), and
MT (p < 0.001, g = 1.47). RISR also yielded a significant mTOR reduction (p = 0.031, g = −1.40).
Conversely, RM statistically increased only MT (p = 0.003, g = 0.80). Between-group effect sizes
supported RISR for type I CSA (g = 0.48), type II CSA (g = 0.50), ACSA (g = 1.03), MT (g = 0.72),
MHC2X (g = 0.31), MHC2A (g = 0.87), and MHC1 (g = 0.59); with all other effects being of trivial
magnitude (g < 0.20). Our results demonstrated greater adaptations in fiber size, whole-muscle size,
and several key contractile proteins when using RISR compared to RM loading paradigms.
Keywords: muscle fiber; hypertrophy; muscle force; strength; athlete
1. Introduction
Recent evidence has suggested performance outcomes favored resistance training (RT) using
relative intensity (RISR), where training is not performed to muscular failure, compared to repetition
maximum (RM) training, where training to muscular failure is achieved during each resistance
exercise [1]. It was hypothesized that these preferential benefits of RISR training were, in part, due to
superior fatigue management through the use of heavy-and-light training days and non-failure training
sessions used throughout the intervention. Conversely, RM training consisted of very high relative
intensity (i.e., failure) training every session with little variability, possibly impacting the group’s ability
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to recover and adapt appropriately [2]. Performance outcomes, such as maximal force production, rate
of force development, and vertical jump performance [1], are certainly critical in understanding any
training program’s efficacy. However, a more thorough investigation of the underlying mechanisms
within the skeletal muscle tissue is warranted.
Sarcomeres, the functional units of skeletal muscle, are central contributors to the activity and
capability of the muscle. Alterations in protein isoforms within the sarcomere give rise to skeletal
muscle plasticity or changes in phenotype. Myosin heavy-chain (MHC) isoforms are directly related
to the muscle fiber type [3,4] and the shortening velocity of the fiber [5,6]. Alterations and synthesis
of MHC isoforms provide a great deal of information regarding training outcomes. Further, the
addition of more sarcomeres and the MHCs that they contain is the basis for muscle hypertrophy [7].
Because of their degree of involvement in contraction dynamics, these factors are often considered
when examining training outcomes or comparing training programs [4,8,9]. Additionally, myofibrillar
protein synthesis is, in part, controlled by a complex network of cellular signaling pathways [10,11].
Much of the divergence in myofibrillar vs. mitochondrial protein synthesis has been attributed to
the interaction between the protein kinase B (PKB, or Akt)-mammalian target of rapamycin (mTOR)
pathway and the adenosine monophosphate kinase (AMPK)-peroxisome proliferator-activated receptor
gamma coactivator 1-alpha (PGC1α) pathway [12,13]. Activation of the Akt-mTOR pathway has
been shown to increase following RT and plays a key role in the synthesis of myofibrillar proteins
(such as MHC isoforms), while the Akt-mTOR pathway is inhibited via AMPK-PGC1α activation
of the tuberous sclerosis complex 2 (TSC2) [14]. Therefore, when examining responses to training
in the skeletal muscle, it seems prudent to perform at minimum a cursory analysis of these relevant
signaling proteins.
Due to differences in load prescription (e.g., failure vs. non-failure), RISR and RM training may
result in divergent cellular signaling responses, which could affect adaptations to the skeletal muscle
tissue and ultimately performance. Thus, the purpose of the study was to compare the physiological
responses of skeletal muscle between a RM or RISR resistance training program. We hypothesized
that RISR would result in superior gains in muscle size and contractile protein content due to a more
polarized model of training intensity allowing for greater fatigue management.
2. Materials and Methods
2.1. Subjects
Eighteen well-trained males volunteered for the study, however, one subject withdrew before
beginning the training intervention and two others (one from each group) withdrew due to minor
injuries during the study. As a result of these drop outs, 15 subjects (age = 26.94 ± 3.95 years, body
mass = 86.21 ± 12.07 kg, BMI = 27.07 ± 3.08) completed the training intervention and were included in
this analysis. Subject experience with consistent resistance training of at least a 3 days·wk−1 frequency
was 7.7 ± 4.2 years, as confirmed by an exercise history questionnaire and careful questioning by the
investigators. In addition to training history, we considered our subjects to be well trained based
on their baseline isometric mid-thigh pull peak force (IPF) (4403.61 ± 664.69 N) and allometrically
scaled isometric peak force (IPFa) (226.04 ± 25.81 N/k−0.67). These values are in line with previously
published data in well-trained, competitive athletes [15–17]. The study groups were equated and
formed by matching for baseline IPFa and assignment to either a RISR group using % set-rep best (RISR,
n = 7) or an RM zone group (RM, n = 8) where the final set of each exercise was taken to momentary
muscular failure. It should be noted that group equalization was performed with the initial 18 subjects,
prior to any dropouts. However, an independent samples t-test confirmed that there were no baseline
differences between the groups (p > 0.05). All subjects read and signed an informed consent document
prior to participating in the study, as approved by the university’s Institutional Review Board (ethical
code: 0716.13f).
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2.2. Resistance Training
Training methodology for the current study was extensively outlined in a previously published
manuscript [1]. Both training groups completed resistance training 3 d·wk−1 for 10 weeks on Mondays,
Wednesdays, and Fridays (Tables 1 and 2). Additionally, sprint training was conducted 2 d·wk−1
throughout the intervention on Tuesdays and Thursdays and was identical for both groups.
Table 1. Resistance Training Programs.
RISR RM Zone
Training Block Week (Sets) × (Reps) Day 1 and 2 Day 3
(A) VJ and IMTP Testing
Strength-Endurance
1 3 × 10 80.0% 70.0% 3 × 8−12
2 3 × 10 85.0% 75.0% 3 × 8−12
3 3 × 10 90.0% 80.0% 3 × 8−12
(B) VJ and IMTP Testing
Max-Strength *
4 3 × 5 85.0% 70.0% 3 × 4−6
5 3 × 5 87.5% 72.5% 3 × 4−6
6 3 × 5 92.5% 75.0% 3 × 4−6
7 3 × 5 80.0% 65.0% 3 × 4−6
(C) VJ and IMTP Testing
Overreach 8 5 × 5 85.0% 75.0% 5 × 4−6
(D) VJ and IMTP Testing
Speed-Strength 9 3 × 3 87.5% 67.5% 3 × 2−4
10 3 × 2 85.0% 65.0% 3 × 1−3
(E) VJ and IMTP testing
* Symbolizes down set at 60% of working weight (RISR only), RISR = relative intensity based on sets and repetitions,
RM = repetition maximum, VJ = vertical jump, IMTP = isometric mid-thigh pull.
Table 2. Training Exercises for all subjects.
Training Block Day 1 Day 2 Day 3
Strength-Endurance
Back Squat, Overhead
Press, Bench Press, DB
Tricep Ext.
CG MTP, CG SLDL, BB
Bent-Row, DB Bent
Lateral Raise
Back Squat, Overhead
Press, Bench Press, DB
Tricep Ext.
Max-Strength
Back Squat, Push Press,
Incline Bench Press,
Wtd. Dips
CG MTP, Clean Pull, SG
SLDL, Pull-Ups
Back Squat, Push Press,
Incline Bench Press,
Wtd. Dips
Overreach Back Squat, Push Press, DBStep Up, Bench Press
CG CM Shrug, Clean
Pull, CG SLDL, SA DB
Bent-Row
Back Squat, Push Press, DB
Step Up, Bench Press
Speed-Strength
Back Squat + Rocket Jump,
Push Press, Bench Press +
Med Ball Chest Pass
CG MTP, CG CM Shrug,
Vertical Med Ball Toss
Back Squat + Rocket Jump,
Push Press, Bench Press +
Med Ball Chest Pass
DB = dumbbell, CG = clean grip, MTP = mid-thigh pull, BB = barbell, Ext = extension, Wtd. = weighted, SG =
snatch grip, SLDL = stiff-legged deadlift, SA = single arm, CM = counter-movement.
Both group programs were based on a block-periodization approach [18–20], with the only
difference between training groups being the loading strategy used. The RISR group used submaximal
intensities (i.e., percentages) to guide the training process, while the RM group used maximal loads
within each training session with the set and repetition prescription. Loads were adjusted for the RISR
group based on estimated set-rep bests within each set-rep combination (e.g., 3× 10, 3× 5). Additionally,
the RISR group used heavy and light days consistent with previous research and block-periodization
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concepts [18,19]. Conversely, the RM group adjusted loads based on the maximal load lifted in each
training session, within the RM zone prescription (e.g., 3 × 8−12, 3 × 4−6). The estimated training
volume load was equalized between groups by having each group’s set-and-repetition prescription
aligned with one another (e.g., a 3 × 4−6 RM in the RM group was mirrored with a 3 × 5 in the RISR
group) [1]. The RM zone training necessitated that each subject would reach muscular failure on the
final set of the prescription, indicating a maximum effort had been achieved. These daily maximums
were then used to adjust training loads for the subsequent session. If the failed set resulted in fewer
repetitions than were prescribed in the RM zone, the load was reduced by a minimum of 2.5% for the
next training session. However, if the repetitions achieved on the failed set exceeded the prescription,
the load would be increased by a minimum of 2.5%. All other training factors not pertaining to the
loading strategy were controlled to the best of our ability (e.g., coaching, training time).
Both groups performed the same dynamic warm-up preceding each training session and performed
the same lift-specific warm-up procedures during resistance training. Specifically, each subject
performed three progressive sets of warm-ups for each of the major lifts (squats, pulls, and presses).
Maximum effort was encouraged on every set of every exercise throughout the intervention. Subjects
were highly motivated and completed 100% of the prescribed training. Subjects were instructed
to refrain from excess physical activity outside of training and on rest days. Lastly, every training
session was closely supervised by multiple certified strength and conditioning coaches throughout
the intervention.
2.3. Muscle Biopsy Sampling and Processing
Muscle biopsies were sampled at rest at least 72 h before any study activity and 72 h after the
final training session. Following an overnight fast, a percutaneous needle biopsy of the vastus lateralis
(VL) was obtained using a 5 mm Bergstrom-Stille biopsy needle under suction [21,22] and local
anesthetic (1% lidocaine). The specimen was obtained in the superficial region of the VL at a depth of
approximately 3 cm for both pre- and post-testing using the double-sample technique. Additionally,
care was taken to obtain the post-sample at a distance 0.5 cm distal of the pre-sample and at the
same tissue depth. After removal of fascia and other tissue, about half of the 50–100 mg sample was
mounted on cork, quickly frozen in isopentane, and cooled in liquid nitrogen for later sectioning on a
cryostat (Leica, Wetzlar, Germany) and immunohistochemical analysis. The remainder of the sample
was placed in a container and frozen in an isopentane slurry cooled over liquid nitrogen. All samples
were then promptly stored at −80 ◦C until they were needed for analysis.
The cork-mounted biopsy samples were removed from the −80 ◦C freezer and allowed to thaw to
−20 ◦C. Serial sections were obtained of each sample at a thickness of 14 µm and affixed to a microscope
slide. Following this, tissues were fixed with acetone at −20 ◦C for five minutes. All samples were
blocked for two hours in a 10% normal goat serum and incubated overnight in monoclonal antibodies
specific to myosin heavy-chain (MCH) isoforms: MHC2X for type IIX fibers (IgM, 1:10 dilution),
MHC2A for type IIA fibers (IgG1, 1:100 dilution), and MHC1 for type I fibers (IgG2b, 1:200 dilution).
Each of these antibodies were obtained from the Developmental Studies Hybridoma Bank (DSHB,
University of Iowa, Iowa, USA). The following day, sections were incubated for two hours using goat
anti-mouse AlexaFluor 488 (IgM), AlexaFluor 350 (IgG1), and AlexaFluor 555 (IgG2b), each at 1:200
dilution (Invitrogen, Carlsbad, CA, USA). A series of photographs were taken of the slides at 10×
magnification using an Olympus BX41 microscope and imaged using an Olympus Qcolor3 camera.
Images were processed in the ImageJ software (National Institute of Health, USA). A total of 3018 fibers
were measured using the software’s tracing tool (100.6 fibers/sample on average), and the average
circularity of the measured fibers was 0.77 ± 0.09. Fiber types were identified and sized based on the
staining color within each fiber (Figure 1). Of the 30 biopsy samples (pre-and-post), only 13 of them
were positive for type IIX muscle fibers (of those 13, only five had greater than 10 type IIX fibers).
Therefore, type IIX and type IIA fiber sizes were not separated for statistical analyses.
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Prior to immunoblot processing, a s all piece of tissue as re oved fro −80 ◦C storage and
kept on dry ice. uscle ho ogenates ere prepared by separating 25–50 g of uscle into a solution
consisting of 500 µL 0.25 sucrose, 20 P S buffer, an protease inhibitors ( alt Protease
Inhibitor Cocktail Kit; Pierce, c f r , I , USA). This solution was then homogenized with 2–3 15-s
bursts of a homogenizer (Pell t stl t r; t s, i la d, J) as previously described [23].
Antibodies raised against mTOR and AMPK were purchased from Cell Signaling (Danvers, MA, US ),
while MHC2X and MHC1 were purchased f om Sigma Aldrich (St. Louid, MO, USA). Antibodies
for MHC2A were obtained from the DSHB as mentioned above. For mTOR and AMPK analysis,
s mples containing 10 µg of protein was applied to 3% to 8% polyacr lamide gradient gels for
immunoblotting, while 5 µg of protein was used for MHC2X, MHC2A, and MHC1. Following one hour
of electrophoresis at 150 V, each gel was tr nsferred to a polyvinylidene difluoride membrane. This
transfer was performed for 90 min at 80 V. Each im unoblot was blocked in 5% nonf t dry milk for two
hours prior to overnight incubation in the primary antibody. The following day, appropriate sec ndary
antibodies were used at 1:5000 dilution for two hours prior to chemiluminescent imaging using a
Syngene G:Box iChemi XT. Each of the samples were run in duplicate and the pre- and post-samples for
each subject were run on the same gel (Figure 2). The odd numbered lanes on each gel contained the
pre-samples, while the next even numbered lane contained the post samples for each respective subject.
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(AMPK), and the myosin heavy-chain (MHC) isoforms: MHC2X, MHC2A, nd MHC1. Immun blots
were p rformed with a marker in the first lane, followed by the first subject’s pre-value and their
post-value. This was repeated for all subjects and proteins.
2.4. Ultrasonography
Anatomical cross-sectional area (ACSA) and muscle thickness (MT) of the right leg, mid-vastus
lateralis (VL) was assessed using ultrasonography (LOGIQ P6, General Electric Healthcare, Wauwatosa,
WI, USA) on each subject before and after the intervention. Ultrasonography was performed 48–72 h
following the most recent training. Prior to measurement, each subject’s hydration status was
determined using refractometry (Atago, Tokyo, Japan) to ensure level of hydration would not affect
the ultrasonography measures. Each subject began the ultrasonography session by lying on their left
side with an internal knee angle of 170 ± 5◦. To determine measurement site, landmarks were found
and marked at the greater trochanter and lateral epicondyle of the femur. The length between these
landmarks was the femur length, and 50% of this length was marked and used as the measurement site.
Additionally, another marking was placed 5 cm medial to the 50% femur mark for MT measurement.
The athlete’s femur length was recorded and used for subsequent testing sessions to ensure proper
placement of the probe. Additionally, probe placement and orientation were verified by comparing
adipose and connective tissue markings from previous images to the current image.
Following application of a water-soluble transmission gel, a 16 Hz ultrasonography probe was
oriented perpendicular to the VL at 50% femur length. ACSA images were obtained using a panoramic
sweep in the transverse plane of the VL using the LOGIQView function of the ultrasound device. For
MT, the probe was oriented 5 cm medial to the mid-femur marking parallel with the VL. Utmost care
was given to not depress the skin or tissues during measurement. Vastus lateralis ACSA was measured
by tracing the inter-muscular interface in the cross-sectional images, and MT was measured as the
distance between subcutaneous adipose tissue-muscle interface and inter-muscular interface. Three
images were collected for each subject and were analyzed on the ultrasonography instrument. Nearly
perfect reliability was observed using intraclass correlation coefficient (ACSA ICC = 0.99, CV = 1.75%;
MT ICC = 1.00, CV = 0.77%); the three images were averaged together for statistical analysis.
2.5. Statistical Analysis
Data were assessed for normality using a Shapiro–Wilk test and for homogeneity of variance using
a Levene’s test. To ensure that drop-outs did not affect baseline group differences, an independent
samples t- est was performed and revealed no significant between-group differences at baseline
(p > 0.05). A 2 × 2 (group × time) mixed design analysis of variance (ANOVA) was used to examine
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main effects for each of the variables derived from the muscle biopsy samples and ultrasonography.
Statistically significant main effects were further examined using Holm’s sequential Bonferroni post-hoc
adjustment. Effect size using Hedge’s g with 90% confidence intervals (CI) was calculated for each
pre-post variable within-group and between-group effects to further examine the practical significance
of these results. Effect size values of 0.0, 0.2, 0.6, 1.2, 2.0, and 4.0 were interpreted as trivial, small,
moderate, large, very large, and nearly perfect, respectively [24]. The alpha level before post-hoc
adjustments was set as p ≤ 0.05. Statistical analyses were performed on a commercially available
statistics software (JASP version 0.8.1.1) and Microsoft Excel 2016 (Microsoft Corporation, Redmond,
WA, USA).
3. Results
For measurement of muscle size, type I CSA, type II CSA, and MT each resulted in statistically
significant main effects for time (p < 0.001), while there was a statistically significant interaction effect
for ACSA (p = 0.046). There were no between-group differences at pre or post for ACSA; however,
post-hoc tests revealed statistically significant increases for the RISR group in type I CSA (p = 0.018),
type II CSA (p = 0.012), ACSA (p = 0.002), and MT (p < 0.001). With the exception of MT (p = 0.003),
none of these measurements reached statistical significance for the RM group (p > 0.05) (Figures 3
and 4). However, effect sizes for muscle size measurements revealed small-large effect sizes for the
RISR group and small-moderate changes for the RM group. Between-group effect sizes favored the
RISR group with small-moderate effect magnitudes (Table 3).
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1,399 
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4,883 ± 
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5,493 ± 
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0.50 (−0.33–1.33) 
ACSA (cm2) 0.53 (0.33–
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Table 3. Muscle size effect size using Hedge’s g and 90% confidence intervals for within-group and
between-group effects.
Relative Intensity Effects Repetition Maximum Effects Between-GroupEffects
Variable g (90% CI) pre ± SD post ± SD g (90% CI) pre ± SD post ± SD g (90% CI)
Type I CSA
(µm2)
0.56
(0.22–0.89) 3277 ± 692 3720 ± 793
0.26
(−0.02–0.54) 3470 ± 789 3713 ± 974 0.48 (−0.35–1.31)
Type II CSA
(µm2)
0.81
(0.37–1.26) 4079 ± 1195 5839 ± 1399
0.49
(−0.05–1.02) 4883 ± 1137 5493 ± 1241 0.50 (−0.33–1.33)
ACSA (cm2)
0.53
(0.33–0.73) 39.10 ± 6.25 42.53 ± 5.76
0.14
(0.00–0.28) 40.77 ± 9.22 42.09 ± 8.75 1.03 (0.20–1.86)
MT (cm2)
1.47
(0.99–1.95) 2.12 ± 0.33 3.62 ± 0.32
0.80
(0.46–1.14) 2.48 ± 0.38 2.83 ± 0.43 0.72 (−0.11–1.55)
g = Hedge’s g effect size, CI = 90% confidence interval, SD = standard deviation, CSA = cross-sectional area, ACSA
= anatomical cross-sectional area, MT = muscle thickness.
Basal levels of total mTOR decreased from pre to post, indicated by a statistically significant main
effect for time (p = 0.007). Post-hoc tests revealed a statistically significant decrease in mTOR for the
RISR group (p = 0.031) but not for the RM group (p = 0.08). No statistically significant main effects
were observed for AMPK (p = 0.792), MHC2X (p = 0.072), MHC2A (p = 0.055), or MHC1 (p = 0.090)
(Figure 5). Effect size statistics for the RISR group suggested a large decrease in total mTOR, trivial
changes in total AMPK, and moderate increases for MHC2X, MHC2A, and MHC1. For the RM group,
moderate decreases in mTOR were observed, no change in AMPK, and small increases in each of the
myosin heavy chains. Between-group effect sizes again favored the RISR group for each of the myosin
heavy chains with effect magnitudes ranging from small-moderate. mTOR and AMPK each had trivial
between-group effects (Table 4).Sports 2019, 7, x FOR PEER REVIEW 10 of 13 
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Table 4. Western blot effect size using Hedge’s g and 90% confidence intervals for within-group and
between-group effects.
Relative Intensity Effects Repetition Maximum Effects Between-Group Effects
g (90% CI) Fold Change ± SD g (90% CI) Fold Change ± SD g (90% CI)
mTOR (AU) −1.40(−2.38–−0.43) −0.22 ± 0.21
−0.97
(−1.86–−0.07) −0.23 ± 0.33 0.02 (−0.80–0.85)
AMPK (AU) −0.19(−1.16–0.78) −0.10 ± 0.70
−0.01
(−0.90–0.88) −0.01 ± 0.81 −0.11 (−0.94–0.72)
MHC2X (AU) 0.93(−0.04–1.90) 1.22 ± 1.74
0.44
(−0.46–1.33) 0.61 ± 1.85 0.31 (−0.52–1.14)
MHC2A (AU) 0.96(−0.01–1.93) 1.70 ± 2.34
0.24
(−0.66–1.14) 0.13 ± 0.70 0.87 (0.02–1.73)
MHC1 (AU) 0.78(−0.19–1.75) 0.50 ± 0.85
0.37
(−0.52–1.27) 0.10 ± 0.36 0.59 (−0.27–1.44)
g = Hedge’s g effect size, mTOR = mammalian target of rapamycin, AMPK = adenosine monophosphate protein
kinase, MHC = myosin heavy chain.
4. Discussion
The main purpose of this study was to compare the skeletal muscle physiological alterations
following either a relative intensity or repetition maximum program. In agreement with our hypothesis,
the results of our investigation indicate that adaptations to whole muscle size, fiber size, and greater
accretion of key myofibrillar proteins favored RISR training over RM training. Both groups trained
using the same periodization scheme with no statistical differences in volume load [1], yet the results
seemed to favor the RISR group. We propose that a major contributor to the result was superior fatigue
management in the RISR group and that consistent training to failure in the RM group possibly led to a
reduced ability to adapt in our well-trained sample.
Hypertrophic adaptations at both the whole muscle and single-fiber level favored the RISR over RM
training group, evidenced by the small-to-moderate between-group effect magnitudes (g = 0.48–1.03).
Higher volume loads have been associated with greater increases in muscle size [7]. Even using similar
volume loads [1], the RI group resulted in greater size gains. Previous researchers have suggested
training to failure permits the maximal recruitment of all motor units within a task [25], and thus
provide optimal stimulation of both high- and low-threshold motor units regardless of training intensity.
However, the results of the current investigation are contrary to this hypothesis, as RISR had greater
magnitudes of type 2 and type 1 fiber size increases compared to the RM group. This is possibly due to
a lack of recovery allowed by virtue of consistently training to failure in the RM group, rather than
insufficient stimuli. In support of this, Moran-Navarro et al. [2] recently demonstrated that performing
bench press and back squats to failure delays recovery of neuromuscular performance by up to 24–48 h
post-exercise [2]. Further, the greater hypertrophy in the RISR group supports the use of a broader
loading spectrum (e.g., heavy-and-light days, down sets) within a training week. Indeed, there is a
paucity of data in well-trained individuals comparing the RISR and RM. Thus, to our knowledge, this
study is the first to suggest that RISR yields more optimal adaptations compared to RM for muscle
hypertrophy in strength-trained subjects.
Small-to-moderate between-group effect magnitudes supported the RISR group for MHC2X
(g = 0.31), MHC2A (g = 0.87), MHC1 (g = 0.59). Although statistical significance (p-value) was not
attained for any MHC isoform, the effect magnitudes support the RISR group. Indeed, the lack of
statistical significance, particularly in the cases of MHC2X and MHC2A, may have been a result
of small sample size. Future investigations including larger samples may reveal more information
regarding these effects. The accretion of myofibrillar proteins is an important component of muscular
performance [5,6]. The greater enhancements in MHC isoforms in the RISR group may provide
information to why the RISR group also improved muscular performance more so than the RM
group [1]. Conversely, the RM group’s lesser accretion of MHCs could be due to the increased fatigue
and delayed recovery associated with RT to failure. Previous research has demonstrated failure training
to induce greater levels of fatigue compared to non-failure training [2], which may impact the ability
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for meaningful accretion of myofibrillar proteins. MHC2X and MHC2A showed greater increases for
both groups compared to MHC1, with the former being expressed in type IIX and type IIA muscle
fibers, respectively. This suggests the RT stimulus, particularly in the RISR group, may have selectively
enhanced production of faster isoforms of MHC. Although beyond the scope of the current study,
tapering has been shown to produce an increase in fast MHC expression [26,27]. Thus, the taper
performed by both groups during the last training phase may have influenced these alterations.
Alterations in total mTOR were somewhat small in magnitude compared to MHC (Figure 5).
However, there was a large, statistically significant decrease in mTOR in the RISR group (g = −1.40),
and a moderate, non-statistically significant decrease for the RM group (g = −0.97). Additionally, there
were no significant changes in total AMPK levels in either group. The decreases in total mTOR are
interesting, as most research examines mTOR alterations within an acute exercise window (i.e., 0–24 h
post-exercise) and usually measures the level of mTOR (or its targets) activation [14,28–30]. Research
examining the changes in basal total mTOR following RT interventions is sparse [23]. Additionally,
acute mTOR increases are suppressed following repeated RT stimuli [31]. This suggests the decreases
in basal mTOR in the current study may have been a result of a molecular adaptation. Additionally,
there are various other, potentially mTOR-independent mechanisms by which protein translation may
be initiated, such as via the costamere and focal adhesion kinase [32]. Although mTOR is a critical
protein for cellular growth, it is also important to note that there are many interacting and competing
signals within the in vivo environment of a skeletal muscle cell [33,34]. The combinations of these
signals are likely the ultimate contributor to fiber and whole-muscle hypertrophy.
Several limitations within the study should be noted in an effort to bolster the interpretation and
application of these data. First, muscle edema (i.e., swelling) was not accounted for in the ultrasound
measurements of the VL. Previous research has suggested very early hypertrophic responses to training
(~3 weeks) may be due to mostly muscle edema [35]. While this investigation did not control for
edema, ACSA measurements were collected at least 48–72 h post exercise, and the post measurements
were taken following a 10-week training program. Additionally, nutritional intake was not controlled
between groups. Nutrient availability plays a role in the acute activation of intracellular signaling
proteins mTOR and AMPK [36]; therefore, readers should exercise caution when interpreting the
results of the chronic changes in signaling proteins observed in this investigation. However, it should
be noted that changes in body mass across the study were not different between groups (p > 0.05) [1].
This indicates caloric intake did not differ greatly between training groups.
5. Conclusions
These results demonstrated a greater effect for fiber and whole-muscle CSA following RISR
compared to RM training in well-trained males. Along with the increased muscle hypertrophy, the
RISR group increased the content of several key MHC isoforms to a greater extent than the RM group,
which may be explained by the greater variation in workload distribution in the RISR group through
the use of heavy and light training and non-failure training sessions. These results, taken together
with the previously published performance data [1], support the use of RISR training in well-trained
populations over that of RM training.
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